Cancer’s future may lie in combination therapy—pairing treatments to outsmart tumors, boost survival, and bring new hope ...

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy ...

The efficacy and safety of rivaroxaban monotherapy are consistent across all age groups of patients with atrial fibrillation and stable coronary artery disease, a study confirms.

Treating psoriatic arthritis (PsA) patients with more than one targeted therapy appears to be just fine, with no increased ...

Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit ...

Researchers found that adding a third immune-targeting drug to existing therapies helped shrink tumors in lab models of ...

Immune checkpoint blockade medications have revolutionized cancer treatment, giving patients and providers new hope to control and sometimes cure metastatic cancer. However, predicting which patients ...

In this video from the American Society of Retina Specialists annual meeting, Charles C. Wykoff, MD, PhD, FASRS, discusses ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

Being diagnosed with a disease like prostate cancer is a very impactful life event, making it vital to have people you love ...

Health Canada grants marketing approval to Roche’s Columvi for R/R diffuse large B-cell lymphoma after initial therapy: Mississauga, Canada Saturday, August 23, 2025, 17:00 Hrs ...

Menopause can usher in a host of disruptive symptoms like hot flashes, night sweats and sleep problems. Hormone therapy ...